Ballard-Barbash R, Potosky A L, Harlan L C, Nayfield S G, Kessler L G
Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD 20892-7344, USA.
J Natl Cancer Inst. 1996 Jun 5;88(11):716-26. doi: 10.1093/jnci/88.11.716.
In addition to demographic and health care-related characteristics, the age and physiologic status of women at the time of breast cancer diagnosis have been reported to influence receipt of standard treatments. Previous studies of the influence of age and comorbidity have not examined whether other patient-, region-, or health care-related characteristics altered the association of age and comorbidity with type of treatment received.
This study examined factors associated with receipt of breast-conserving surgery and radiation therapy, both of which are recommended treatments for breast cancer, among a cohort of 18,704 women aged 65 years or more who had breast cancer diagnosed during the period from 1985 through 1989.
A data file linking Medicare claims records to data from the Surveillance, Epidemiology, and End Results (SEER) Program of the U.S. National Cancer Institute was utilized. Logistic regression analysis was used to examine associations between patient, region, and hospital characteristics and the receipt of specific treatments. The likelihood test was used to assess the significance of observed associations (expressed as odds ratios [ORs]). Because of multiple comparisons, only those ORs with two-sided P values <.01 were considered statistically significant.
The frequency of breast-conserving surgery was highest (54%) among women aged 80 years or more, who had two or more comorbid conditions and stage I disease. However, in general, the receipt of radiation therapy among women undergoing breast-conserving surgery declined markedly with age, irrespective of comorbidity status and disease stage. Between the ages of 65-69 years and 80 years or older, radiation therapy declined from 77% to 24% among women with no comorbid conditions and from 50% to 12% among women with two or more comorbid conditions. In regression models that included hospital, region, and patient characteristics as variables, age and comorbidity remained independently associated with the receipt of radiation therapy (OR = 0.12 and 95% confidence interval [CI] = 0.10-0.14 for women aged 80 years or more compared with women 65-69 years of age and OR of 0.33 [95% CI = 0.24-0.46] for women with two or more comorbid conditions versus no comorbid conditions).
After adjustment for multiple clinical and nonclinical factors influencing treatment, chronologic age remains an important independent factor associated with the receipt of radiation therapy after breast-conserving surgery among women aged 65 years or more who were diagnosed with early stage breast cancer.
Future studies should determine whether these differences in treatment patterns among older women result in increased morbidity (e.g., from recurrence), shortened disease-free or overall survival, or decreased quality of life.
据报道,除了人口统计学和医疗保健相关特征外,乳腺癌诊断时女性的年龄和生理状态也会影响标准治疗的接受情况。先前关于年龄和合并症影响的研究并未考察其他患者、地区或医疗保健相关特征是否改变了年龄和合并症与所接受治疗类型之间的关联。
本研究在1985年至1989年期间确诊患有乳腺癌的18704名65岁及以上女性队列中,考察了与保乳手术和放射治疗接受情况相关的因素,这两种治疗均为乳腺癌的推荐治疗方法。
利用了一个将医疗保险理赔记录与美国国立癌症研究所监测、流行病学和最终结果(SEER)计划的数据相链接的数据文件。采用逻辑回归分析来考察患者、地区和医院特征与特定治疗接受情况之间的关联。似然检验用于评估观察到的关联的显著性(以比值比[OR]表示)。由于进行了多次比较,仅将双侧P值<.01的那些OR视为具有统计学显著性。
在80岁及以上、患有两种或更多合并症且处于I期疾病的女性中,保乳手术的频率最高(54%)。然而,总体而言,接受保乳手术的女性中放射治疗的接受率随年龄显著下降,无论合并症状态和疾病阶段如何。在65 - 69岁和80岁及以上年龄段之间,无合并症的女性放射治疗率从77%降至24%,患有两种或更多合并症的女性从50%降至12%。在将医院、地区和患者特征作为变量纳入的回归模型中,年龄和合并症仍然与放射治疗的接受独立相关(80岁及以上女性与65 - 69岁女性相比,OR = 0.12,95%置信区间[CI] = 0.10 - 0.14;患有两种或更多合并症的女性与无合并症的女性相比,OR为0.33[95%CI = 0.24 - 0.46])。
在对影响治疗的多种临床和非临床因素进行调整后,对于确诊患有早期乳腺癌的65岁及以上女性,实际年龄仍然是保乳手术后接受放射治疗的一个重要独立相关因素。
未来的研究应确定老年女性治疗模式的这些差异是否会导致发病率增加(例如,因复发)、无病生存期或总生存期缩短或生活质量下降。